NIOSHTIC-2 Publications Search
Walk-through survey report exposure to estrogens at Schering Corporation, Union, New Jersey.
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, IWS 85-20, 1980 Jun; :1-11
Worker exposure to estrogens was investigated at Schering Corporation (SIC-2834) in Union, New Jersey on August 30, 1978. The company was included in a preliminary study of pharmaceutical firms processing estrogens. About 80 male and 200 female employees were involved in the estrogen products manufacturing process. Full personnel records for active workers and partial records for retired, terminated, or deceased workers were maintained. The company had a manager of safety services and a safety committee, which met monthly. The company also had a full time medical director and several nurses. Preemployment medical examinations were given. No industrial hygiene sampling during estrogen production operations was conducted. The authors conclude that the potential for exposure of employees is high during production cycles because of the open processing methods. Mortality and reproductive studies at the facility are unfeasible because of the short period between termination of employment and destruction of records (7 years), limited product exposure information, and the limited amount of women that work in the manufacturing area.
NIOSH-Author; NIOSH-Survey; Field-Study; Region-2; Estrogenic-hormones; Chemical-manufacturing-industry; Health-surveys; Worker-health; Industrial-hygiene
Field Studies; Industry Wide
NTIS Accession No.
National Institute for Occupational Safety and Health
Page last reviewed: September 2, 2020
Content source: National Institute for Occupational Safety and Health Education and Information Division